Delivery Order SPE2DB22D3016-SPE2DB24FAZN7

Award Date 6/26/24
Potential Completion Date 6/27/24
Potential Value $1.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,657.35 firm fixed-price delivery order is for the supply of the drug Junel FE 1.5 mg-30 mcg tablets, with an ultimate completion date of October 21, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which...
This federal contract award is for the delivery of pharmaceutical products, specifically the drug Junel FE 1 mg-20 mcg tablet in 28-count packages, to the Defense Logistics Agency (DLA), a component of the Department of Defense. The $5,253.02 delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $1,904.40 for the supply of pharmaceutical products, including the drug Junel FE 1 mg-20 mcg tablet. The contract has an ultimate completion date of April 9, 2025 and utilizes a Firm Fixed Price pricing type. This award is part of a larger Indefinite Delivery Contract (IDC)...
This federal contract award, valued at $1,192.59, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of the pharmaceutical product JUNEL FE 1 MG-20 MCG TABLET 28S. The contract has an ultimate completion date of May 20, 2025 and is a Firm Fixed Price agreement. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This is a federal contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $1,244.76, with a firm fixed price and a completion date of January 6, 2025. The contract is for the supply of a pharmaceutical product, JUNEL FE 1 MG-20 MCG Tablet 28S, to support military healthcare programs. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of the medication Junel Fe 1 mg-20 mcg tablet. The contract has a firm fixed price of $1,104.20 and an ultimate completion date of August 29, 2024. It is a delivery order contract with no set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This contract award is for the supply of medical products, specifically the generic pharmaceutical Junel FE 1 mg-20 mcg tablets, to the Defense Logistics Agency (DLA). The contract, valued at $3,626.49, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle for providing a...
This federal contract award is a delivery order with a firm fixed price of $1,376.34 issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, awarded by the Defense Logistics Agency (DLA), has an ultimate completion date of January 15, 2025 and covers the procurement of Junel FE 1 mg-20 mcg tablets. This award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $2,209.72, is for the delivery of JUNEL FE 1 MG-20 MCG TABLET 28S, which are likely pharmaceutical products used in defense or civilian medical applications. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued at $999,999,999 and...
This federal contract award, valued at $1,104.48, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Junel FE 1 mg-20 mcg tablets. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for the company to provide a comprehensive range of...
  • SPE2DB22D3016
    Indefinite Delivery Contract
  • SPE2DB22D3016-SPE2DB24FAZN7
    Delivery Order

This federal contract award is for pharmaceutical products, specifically the delivery of Junel Fe 1 mg-20 mcg tablets, to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, and has a total ceiling value of $1,491.52. The contract is a delivery order with a firm fixed price pricing type and a performance period through June 27, 2024.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

The contract award did not have a set-aside designation, indicating open competition.

Generated 5/17/25, 9:55 AM